Literature DB >> 3571458

Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.

J A Hindler, D A Bruckner.   

Abstract

The AutoMicrobic system (AMS; Vitek Systems, Inc., Hazelwood, Mo.) was compared with a reference broth microdilution MIC method to determine the accuracy and reproducibility of aminoglycoside susceptibility testing of gram-negative bacilli. Stock clinical isolates (n = 176) which demonstrated resistance to at least one aminoglycoside, extended-spectrum penicillin, or broad-spectrum cephalosporin (or a combination) were selected for this study. Isolates with moderate susceptibility to the aminoglycosides were also included. Of these isolates, 116 were either resistant or moderately susceptible to one or more of amikacin, gentamicin, netilmicin, and tobramycin. When AMS MIC results for 704 antimicrobial agent-organism combinations were compared with parallel microdilution MIC results, exact agreement (AMS MIC = reference MIC) rates were: amikacin, 71.6%; gentamicin, 71.6%; netilmicin, 83.0%; and tobramycin, 69.3%. Agreement rates within +/- 1 log2 dilution were: amikacin, 96.0%; gentamicin, 93.8%; netilmicin, 97.2%; and tobramycin, 96.0%. When National Committee for Clinical Laboratory Standards criteria were used to qualitatively evaluate performance, the overall agreement rates were: amikacin, 100.0%; gentamicin, 99.4%; netilmicin, 98.9%; and tobramycin, 99.4%. There were only four very major discrepancies, which represented 0.6% of the tests performed, and there were no major discrepancies. The percentages of minor discrepancies were: amikacin, 9.6%; gentamicin, 14.2%; netilmicin, 11.9%; and tobramycin, 10.8%. Of the overall average of 11.6% minor discrepancies, 9.7% occurred even though the AMS MIC was within +/- 1 log2 dilution of the reference MIC. The intralaboratory reproducibility ranged from 93.3 to 100% for the four drugs examined. With this challenge group of gram-negative bacilli, the AMS generated aminoglycoside MIC results that were comparable to those obtained by a reference broth microdilution method.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571458      PMCID: PMC265985          DOI: 10.1128/jcm.25.3.546-550.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Accuracy and reproducibility of the AutoMicrobic System Gram-Negative General Susceptibility-Plus Card for testing selected challenge organisms.

Authors:  H L Nadler; C Dolan; L Mele; S R Kurtz
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

2.  Rapid antimicrobial susceptibility testing of Gram-negative clinical isolates with the AutoMicrobic system.

Authors:  B A Backes; S J Cavalieri; J T Rudrik; E M Britt
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

3.  Evaluation of the AutoMicrobic system Gram-Negative General Susceptibility-Plus Card.

Authors:  K G Van Horn; A M Vandernoot; E W Burke; J C McKitrick
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

4.  Comparison of the Cathra Repliscan II, the AutoMicrobic system Gram-Negative General Susceptibility-Plus Card, and the Micro-Media System Fox Panel for dilution susceptibility testing of gram-negative bacilli.

Authors:  N E Reiber; M T Kelly; J M Latimer; D L Tison; R M Hysmith
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; M N Ederer; C O Quall
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

  5 in total
  2 in total

1.  Comparison of Vitek and Cobas Micro systems with a semiautomated conventional microsystem for identification and susceptibility testing of gram negative bacilli.

Authors:  A M Simoons-Smit; D M Maclaren
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

2.  Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  G V Doern; A B Brueggemann; R Perla; J Daly; D Halkias; R N Jones; M A Saubolle
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.